BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 33528032)

  • 1. Prognostic value of serum HE4 level in the management of endometrial cancer: A pilot study.
    Rajadevan N; McNally O; Neesham D; Richards A; Naaman Y
    Aust N Z J Obstet Gynaecol; 2021 Apr; 61(2):284-289. PubMed ID: 33528032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HE4 and CA125 as preoperative risk stratifiers for lymph node metastasis in endometrioid carcinoma of the endometrium: A retrospective study in a cohort with histological proof of lymph node status.
    O'Toole SA; Huang Y; Norris L; Power Foley M; Shireen R; McDonald S; Kamran W; Ibrahim N; Ward M; Thompson C; Murphy C; D'Arcy T; Farah N; Heron E; O'Leary JJ; Abu Saadeh F; Gleeson N
    Gynecol Oncol; 2021 Feb; 160(2):514-519. PubMed ID: 33213897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CA125 and HE4 levels in a Czech female population diagnosed with endometrial cancer in preoperative management.
    Presl J; Novotny Z; Topolcan O; Vlasak P; Kucera R; Fuchsova R; Vrzalova J; Betincova L; Svobodova S
    Anticancer Res; 2014 Jan; 34(1):327-31. PubMed ID: 24403483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of preoperative HE4 as predictor of advanced disease in endometrioid endometrial cancer.
    Espiau Romera A; Coronado Martín PJ; Chóliz Ezquerro M; Cuesta Guardiola T; Adiego Calvo I; Baquedano Mainar L
    Int J Gynaecol Obstet; 2021 Apr; 153(1):64-70. PubMed ID: 33156532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of serum HE4 with tumor size and myometrial invasion in endometrial cancer.
    Kalogera E; Scholler N; Powless C; Weaver A; Drapkin R; Li J; Jiang SW; Podratz K; Urban N; Dowdy SC
    Gynecol Oncol; 2012 Feb; 124(2):270-5. PubMed ID: 22037318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HE4 tumor marker as a predictive factor for lymphatic metastasis in endometrial cancer.
    Espiau Romera A; Cuesta Guardiola T; Benito Vielba M; De Bonrostro Torralba C; Coronado Martín PJ; Baquedano Mainar L
    Int J Gynaecol Obstet; 2020 Jun; 149(3):265-268. PubMed ID: 32147821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of novel biomarker HE4 in endometrial cancer: a case control prospective study.
    Angioli R; Plotti F; Capriglione S; Montera R; Damiani P; Ricciardi R; Aloisi A; Luvero D; Cafà EV; Dugo N; Angelucci M; Benedetti-Panici P
    Tumour Biol; 2013 Feb; 34(1):571-6. PubMed ID: 23179397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Serum HE4 with Primary Tumor Diameter and Depth of Myometrial Invasion in Endometrial Cancer Patients at Rajavithi Hospital.
    Prueksaritanond N; Cheanpracha P; Yanaranop M
    Asian Pac J Cancer Prev; 2016; 17(3):1489-92. PubMed ID: 27039795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HE4 and CA125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (ENDOMET).
    Antonsen SL; Høgdall E; Christensen IJ; Lydolph M; Tabor A; Loft Jakobsen A; Fagö-Olsen CL; Andersen ES; Jochumsen K; Høgdall C
    Acta Obstet Gynecol Scand; 2013 Nov; 92(11):1313-22. PubMed ID: 24032654
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative Serum Human Epididymis Protein 4 Levels in Early Stage Endometrial Cancer: A Prospective Study.
    Fanfani F; Restaino S; Cicogna S; Petrillo M; Montico M; Perrone E; Radillo O; De Leo R; Ceccarello M; Scambia G; Ricci G
    Int J Gynecol Cancer; 2017 Jul; 27(6):1200-1205. PubMed ID: 28557834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The importance of HE4 in differential diagnosis of endometrial cancer].
    Minář L; Klabenešová I; Jandáková E
    Ceska Gynekol; 2015 Aug; 80(4):256-63. PubMed ID: 26265413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum HE4 and CA125 combined to predict and monitor recurrence of type II endometrial carcinoma.
    Quan Q; Liao Q; Yin W; Zhou S; Gong S; Mu X
    Sci Rep; 2021 Nov; 11(1):21694. PubMed ID: 34737393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of serum HE4 as a prognostic marker in carcinoma of the ovary.
    Lakshmanan M; Kumar V; Chaturvedi A; Misra S; Gupta S; Akhtar N; Rajan S; Jain K; Garg S
    Indian J Cancer; 2019; 56(3):216-221. PubMed ID: 31389384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does HE4 have a role as biomarker in the recurrence of ovarian cancer?
    Plotti F; Capriglione S; Terranova C; Montera R; Aloisi A; Damiani P; Muzii L; Scaletta G; Benedetti-Panici P; Angioli R
    Tumour Biol; 2012 Dec; 33(6):2117-23. PubMed ID: 22875782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of Preoperative Knowledge of the Biomarker HE4 in Early-stage Endometrial Cancer Regarding Surgical Management.
    Presl J; Ovesna P; Novotny Z; Vlasak P; Bouda J; Kostun J; Topolcan O; Kucera R; Bednarikova M; Weinberger V
    Anticancer Res; 2017 May; 37(5):2697-2702. PubMed ID: 28476847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative markers for the prediction of high-risk features in endometrial cancer.
    Panyavaranant P; Manchana T
    World J Clin Oncol; 2020 Jun; 11(6):378-388. PubMed ID: 32874951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum HE4 as a prognostic marker in endometrial cancer--a population based study.
    Brennan DJ; Hackethal A; Metcalf AM; Coward J; Ferguson K; Oehler MK; Quinn MA; Janda M; Leung Y; Freemantle M; ; Webb PM; Spurdle AB; Obermair A
    Gynecol Oncol; 2014 Jan; 132(1):159-65. PubMed ID: 24211402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HE4 is superior to CA125 in the detection of recurrent disease in high-risk endometrial cancer patients.
    Abbink K; Zusterzeel PL; Geurts-Moespot AJ; Herwaarden AEV; Pijnenborg JM; Sweep FC; Massuger LF
    Tumour Biol; 2018 Feb; 40(2):1010428318757103. PubMed ID: 29463191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
    Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
    PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of human epididymis protein 4 in endometrial cancer and its utility for surgical staging.
    Minar L; Klabenesova I; Jandakova E; Zlamal F; Bienertova-Vasku J
    J Obstet Gynaecol Res; 2015 Oct; 41(10):1644-52. PubMed ID: 26223178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.